Drug misuse - methadone and buprenorphine: Review Proposal - August 2010

Review of NICE Technology Appraisal Guidance No 114; Methadone and buprenorphine for the management of opioid dependence

 Proposal to move guidance to the static list

The planned date for review of the above guidance is March 2010.

This is the date at which the Institute decides whether sufficient new evidence has emerged for the Appraisal Committee to be asked to undertake a full review appraisal.

Having re-run the search strategy from the original assessment report the Institute has not found any relevant additions to the evidence base that would have a material effect on the guidance. Consequently we propose that the original guidance become static.

Topics on the static list may be transferred back to the active list for further appraisal if new evidence becomes available that is likely to have a material effect on the last guidance issued.

In order to be completely confident that this is appropriate, we are asking all relevant consultees and commentators, to inform us of any evidence which would suggest that a review would be beneficial.  Please see appendix A for a full list of the organisations we have contacted. 

August 2010

This page was last updated: 26 December 2010